ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,480,164, issued on Nov. 25, was assigned to EpiMedTechGlobal (EMTG) (Singapore).
"DNA methylation biomarkers for early detection of cervical cancer" was invented by Moshe Szyf (Cote St Luc, Canada), David Cheishvili (Pierrefonds, Canada), Eduardo Franco (Montreal) and Mariam El-Zein (Montreal).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention discloses an in vitro method for obtaining DNA methylation biomarkers as exquisite DNA methylation positions in the human genome (i.e., CGIDs) that predict cervical cancer especially at as yet inaccessible early stages by examining progression of "categorical" DNA methylation alterations in three ...